Why DexCom Inc. (DXCM) Soared Last Week

We recently published a list of These 10 Firms Soared Last Week, Here’s Why. In this article, we are going to take a look at where DexCom Inc. (NASDAQ:DXCM) stands against other firms that soared last week.

The past trading week saw a more calm, generally optimistic, market environment amid the temporary pause in tit-for-tat tariffs, buoyed further by a flurry of corporate earnings for the first quarter of the year.

On a week-on-week basis, the tech-heavy Nasdaq rallied the most, up 3.4 percent, followed by the Dow Jones with 3 percent, and the S&P 500 by 2.9 percent.

Beyond the major indices, 10 firms stood out, booking double-digit gains as high as 48 percent, thanks to better-than-expected earnings and outlook.

In this article, we name this week’s 10 best-performing mid-cap companies and detail the reasons behind their gains.

To come up with the list, we considered only the stocks with a $2-billion market capitalization and $5-million trading volume. The stocks were chosen based on the highest percentage increase in closing prices on May 2 as against their prices a week earlier, or on April 25.

A doctor demonstrating how to use the medical device to a patient with diabetes.

DexCom Inc. (NASDAQ:DXCM)

DexCom Inc., an American healthcare company, saw its share prices jump by 13.9 percent during the past trading week, closing at $81.62 last Friday versus the $71.66 the week prior, after reaffirming its revenue guidance and reporting robust sales in the first quarter of the year.

In a statement, DexCom Inc. (NASDAQ:DXCM) reiterated its target 14-percent revenue growth for the full year 2025 at $4.6 billion, as the company readies itself with the launch of its Dexcom G7 15 Day system, a small wearable sensor that sends accurate and real-time glucose readings.

In the first three months of the year, DexCom Inc. (NASDAQ:DXCM) reported a 28-percent decline in its net income at $105.4 million versus the $146.4 million registered in the same period last year.

However, revenues increased by 12.49 percent to $1.036 billion from $921 million year-on-year.

Overall, DXCM ranks 10th on our list of firms that soared last week. While we acknowledge the potential of DXCM as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than DXCM but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.